Efficacy and safety outcomes in patients with progressive familial intrahepatic cholestasis who had an odevixibat dose escalation: pooled results from the PEDFIC 1 and PEDFIC 2 studies.

Authors :: Grammatikopoulos, T.
Dalgic, B.
Gupte, G.
Lacaille, F.
Lachaux, A.
Roquelaure, B.
Baumann, U.
Sturm, E.
Calvo, P. L.
Artan, R.
Özen, H.
Rajwal, S. R.
Mack, C. L.
Ni, Q.
Kjems, L.
Horn, P.
Source :: Journal of Pediatric Gastroenterology & Nutrition; 2022 Supplement, Vol. 74, p645-646, 2p
Publication Year :: 2022

Full Text Access

Tools